Optimal planning target margin for prostate radiotherapy based on interfractional and intrafractional variability assessment during 1.5T MRI-guided radiotherapy

被引:1
作者
Kim, Jina [1 ]
Sung, Jiwon [1 ]
Lee, Seo Jin [1 ]
Cho, Kang Su [2 ]
Chung, Byung Ha [2 ]
Yang, Dongjoon [1 ]
Kim, Jihun [1 ]
Kim, Jun Won [1 ]
机构
[1] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Radiat Oncol, Seoul, South Korea
[2] Yonsei Univ, Gangnam Severance Hosp, Prostate Canc Ctr, Dept Urol,Coll Med, Seoul, South Korea
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
基金
新加坡国家研究基金会;
关键词
prostate cancer; PTV margin; MRI-guided radiotherapy; interfractional setup margin; intrafractional motion; interobserver variability; HYPOFRACTIONATED RADIOTHERAPY; DEFINITIVE RADIOTHERAPY; CANCER; MOTION; DELINEATION; TOXICITY; CT;
D O I
10.3389/fonc.2023.1337626
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
IntroductionWe analyzed daily pre-treatment- (PRE) and real-time motion monitoring- (MM) MRI scans of patients receiving definitive prostate radiotherapy (RT) with 1.5 T MRI guidance to assess interfractional and intrafractional variability of the prostate and suggest optimal planning target volume (PTV) margin.Materials and methodsRigid registration between PRE-MRI and planning CT images based on the pelvic bone and prostate anatomy were performed. Interfractional setup margin (SM) and interobserver variability (IO) were assessed by comparing the centroid values of prostate contours delineated on PRE-MRIs. MM-MRIs were used for internal margin (IM) assessment, and PTV margin was calculated using the van Herk formula.ResultsWe delineated 400 prostate contours on PRE-MRI images. SM was 0.57 +/- 0.42, 2.45 +/- 1.98, and 2.28 +/- 2.08 mm in the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions, respectively, after bone localization and 0.76 +/- 0.57, 1.89 +/- 1.60, and 2.02 +/- 1.79 mm in the LR, AP, and SI directions, respectively, after prostate localization. IO was 1.06 +/- 0.58, 2.32 +/- 1.08, and 3.30 +/- 1.85 mm in the LR, AP, and SI directions, respectively, after bone localization and 1.11 +/- 0.55, 2.13 +/- 1.07, and 3.53 +/- 1.65 mm in the LR, AP, and SI directions, respectively, after prostate localization. Average IM was 2.12 +/- 0.86, 2.24 +/- 1.07, and 2.84 +/- 0.88 mm in the LR, AP, and SI directions, respectively. Calculated PTV margin was 2.21, 5.16, and 5.40 mm in the LR, AP, and SI directions, respectively.ConclusionsMovements in the SI direction were the largest source of variability in definitive prostate RT, and interobserver variability was a non-negligible source of margin. The optimal PTV margin should also consider the internal margin.
引用
收藏
页数:8
相关论文
共 37 条
  • [1] Planning target margin calculations for prostate radiotherapy based on intrafraction and interfraction motion using four localization methods
    Beltran, Chris.
    Herman, Michael G.
    Davis, Brian J.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (01): : 289 - 295
  • [2] The role of radiotherapy in localised and locally advanced prostate cancer
    Bolla, Michel
    Henry, Ann
    Mason, Malcom
    Wiegel, Thomas
    [J]. ASIAN JOURNAL OF UROLOGY, 2019, 6 (02) : 153 - 161
  • [3] Online adaptive radiotherapy potentially reduces toxicity for high-risk prostate cancer treatment
    Christiansen, Rasmus Lubeck
    Dysager, Lars
    Hansen, Christian Ronn
    Jensen, Henrik Robenhagen
    Schytte, Tine
    Nyborg, Christina Junker
    Bertelsen, Anders Smedegaard
    Agergaard, Soren Nielsen
    Mahmood, Faisal
    Hansen, Steinbjorn
    Hansen, Olfred
    Brink, Carsten
    Bernchou, Uffe
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 167 : 165 - 171
  • [4] Clough A., 2022, J Med Imaging Radiat Sci, V53, pS17, DOI [10.1016/j.jmir.2022.04.045, DOI 10.1016/J.JMIR.2022.04.045]
  • [5] MR-Guided Hypofractionated Radiotherapy: Current Emerging Data and Promising Perspectives for Localized Prostate Cancer
    Cuccia, Francesco
    Corradini, Stefanie
    Mazzola, Rosario
    Spiazzi, Luigi
    Rigo, Michele
    Bonu, Marco Lorenzo
    Ruggieri, Ruggero
    Bastia, Michela Buglione di Monale e
    Magrini, Stefano Maria
    Alongi, Filippo
    [J]. CANCERS, 2021, 13 (08)
  • [6] Cuccia F, 2020, RADIAT ONCOL, V15, DOI 10.1186/s13014-020-01622-3
  • [7] Definitive radiotherapy for prostate cancer in Norway 2006-2015: Temporal trends, performance and survival
    Fossa, Sophie D.
    Aas, Kirsti
    Mueller, Christoph.
    Jerm, Marianne B.
    Tandstad, Torgrim
    Lilleby, Wolfgang
    Kvale, Rune
    Gulbrandsen, Johanne
    Haug, Erik
    Myklebust, Tor A.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2021, 155 : 33 - 41
  • [8] Quantification of prostate and seminal vesicle interfraction variation during IMRT
    Frank, Steven J.
    Dong, Lei
    Kudchadker, Rajat J.
    De Crevoisier, Renaud
    Lee, Andrew K.
    Cheung, Rex
    Choi, Seungtaek
    O'Daniel, Jennifer
    Tucker, Susan L.
    Wang, He
    Kuban, Deborah A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (03): : 813 - 820
  • [9] Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy
    Gill, S.
    Li, J.
    Thomas, J.
    Bressel, M.
    Thursky, K.
    Styles, C.
    Tai, K. H.
    Duchesne, G. M.
    Foroudi, F.
    [J]. BRITISH JOURNAL OF RADIOLOGY, 2012, 85 (1015) : 1011 - 1017
  • [10] Reducing PTV margins for prostate SBRT with motion compensation and gating techniques
    Goddard, Lee
    Jeong, Kyoungkeun
    Tang, Justin
    Garg, Madhur
    Tome, Wolfgang A. A.
    [J]. JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2023, 24 (04):